Crispr Therapeutics

CRISPR Therapeutics is a biotechnology company focused on developing transformative gene-based medicines using CRISPR/Cas9 technology. They make money through partnerships, licensing agreements, and developing therapies for genetic diseases, including hemoglobinopathies, cancer, and diabetes. Founded in 2013 by Emmanuelle Charpentier and Rodger Novak, the company has been at the forefront of gene editing, with significant milestones such as the development of CTX001 for sickle cell disease and beta-thalassemia.

Recent Posts by Crispr Therapeutics

1-20 of 66